Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Repro-Med Systems, Inc.
483
•Repro-Med Systems, Inc.•December 16, 2016

Repro-Med Systems, Inc. – FDA 483, Dec 16, 2016

Record Details

An FDA inspection conducted from November 29 to December 16, 2016, at Repro-Med Systems, Inc., a medical device manufacturer in Chester, NY, revealed significant deviations from regulatory requirements. The Form FDA-483 identified eight key observations, primarily related to the company's quality management system, particularly concerning its compliance with Good Manufacturing Practices for medical devices. One critical issue was the firm's failure to report a correction and removal (effectively a recall) of potentially compromised sterile needle sets and tubing, which posed a risk of infection, to the FDA. This directly impacts patient safety. The inspection also highlighted inadequate procedures for design changes, with the company failing to verify or validate modifications to ensure product integrity. Further observations included systemic weaknesses in the Corrective and Preventive Action (CAPA) system, such as insufficient verification of corrective actions, incomplete investigations into root causes, and a lack of adherence to internal CAPA procedures. The firm also inadequately controlled nonconforming products, often releasing them without proper evaluation, segregation, or documented justification. Complaint handling procedures were found deficient, with complaints not consistently evaluated for reportability or thoroughly investigated. Additionally, critical rework activities were undocumented, design verification testing lacked sufficient rationale, and records for an important supplier were absent, including its qualification status. Repro-Med Systems, Inc. is required to thoroughly investigate these observations, implement comprehensive corrective actions, and submit a detailed response to the FDA outlining how it will address each deficiency and prevent recurrence.

Company
Repro-Med Systems, Inc.
Inspection date
December 16, 2016
Product type
Devices
Office
New York District Office
Person
  • Scott R. Izyk
View Company Profile

ID · 6594af00-3003-4ed8-889d-5d5fd326cd0c

Other documents for Repro-Med Systems, Inc.
  • 483 - 2017-10-19October 19, 2017

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Repro-Med Systems, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.